Nick B. Tressler insider trades

Open-market stock purchases and sales by Nick B. Tressler, Chief Financial Officer at Vistagen Therapeutics, Inc, from SEC Form 4 filings since Nov 15, 2019.

Recent trades

DateStockTradeValue
Apr 7, 2026VTGN Vistagen Therapeutics, IncBought (not open market)—
Dec 1, 2025VTGN Vistagen Therapeutics, IncBought (not open market)$665K

Companies traded

  • VTGN Vistagen Therapeutics, Inc: other filings, last Apr 7, 2026
  • SENS Senseonics Holdings, Inc: 1 sale, last May 26, 2022

Get free alerts when Nick B. Tressler files a new trade →